Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$203.72 - $248.97 $61,116 - $74,691
-300 Reduced 60.0%
200 $47,000
Q3 2022

Oct 25, 2022

SELL
$204.81 - $262.19 $307,215 - $393,285
-1,500 Reduced 75.0%
500 $102,000
Q2 2022

Jul 18, 2022

BUY
$213.86 - $277.87 $42,772 - $55,574
200 Added 11.11%
2,000 $469,000
Q1 2022

Apr 19, 2022

BUY
$259.82 - $298.18 $25,982 - $29,818
100 Added 5.88%
1,800 $474,000
Q4 2021

Jan 21, 2022

BUY
$271.6 - $314.21 $190,120 - $219,947
700 Added 70.0%
1,700 $534,000
Q3 2021

Oct 12, 2021

BUY
$274.82 - $308.34 $164,892 - $185,003
600 Added 150.0%
1,000 $281,000
Q2 2021

Aug 20, 2021

SELL
$251.87 - $278.14 $705,236 - $778,792
-2,800 Reduced 87.5%
400 $110,000
Q1 2021

Apr 26, 2021

SELL
$204.88 - $255.03 $204,880 - $255,030
-1,000 Reduced 23.81%
3,200 $816,000
Q4 2020

Jan 20, 2021

SELL
$186.91 - $214.42 $1.33 Million - $1.52 Million
-7,100 Reduced 62.83%
4,200 $855,000
Q3 2020

Oct 16, 2020

SELL
$167.03 - $201.3 $317,357 - $382,470
-1,900 Reduced 14.39%
11,300 $2.13 Million
Q2 2020

Jul 23, 2020

SELL
$113.31 - $182.44 $1.45 Million - $2.34 Million
-12,800 Reduced 49.23%
13,200 $2.19 Million
Q1 2020

Apr 23, 2020

BUY
$104.32 - $195.28 $2.71 Million - $5.08 Million
26,000 New
26,000 $3.29 Million
Q1 2019

Apr 09, 2019

SELL
$123.7 - $156.3 $531,910 - $672,090
-4,300 Closed
0 $0
Q4 2018

Jan 15, 2019

SELL
$120.82 - $174.09 $2.54 Million - $3.66 Million
-21,000 Reduced 83.0%
4,300 $543,000
Q3 2018

Oct 09, 2018

BUY
$167.67 - $188.27 $4.24 Million - $4.76 Million
25,300 New
25,300 $4.39 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.